NCT04112043View on ClinicalTrials.gov

Nicotinamide Riboside as an Enhancer of Exercise Therapy in Hypertensive Older Adults (The NEET Trial)

PHASE1CompletedINTERVENTIONAL

Enrollment

147

Participants

Timeline

Start Date

July 28, 2020

Primary Completion Date

May 26, 2023

Study Completion Date

May 26, 2023

Conditions

Hypertension

Interventions

BEHAVIORAL

Walking Exercise

Participants randomized to this intervention 3 days/week of supervised, center-based walking exercise.

DRUG

Nicotinamide Riboside (NR)

Participants randomized to this intervention will receive 1,000 mg/day of NR.

Trial Locations (1)

32611

UF Institute on Aging, Gainesville

All Listed Sponsors

collaborator

National Institute on Aging (NIA)

NIH

lead

University of Florida

OTHER

NCT04112043 - Nicotinamide Riboside as an Enhancer of Exercise Therapy in Hypertensive Older Adults (The NEET Trial) | Biotech Hunter | Biotech Hunter